Fig. 3From: Immunoselected STRO-3+ mesenchymal precursor cells reduce inflammation and improve clinical outcomes in a large animal model of monoarthritisEffect of MPC administration on plasma cytokines in sheep with CIA. Plasma concentrations of activin A (A), and IL-17A (B) were compared between the MPC-treated and control group using two-way ANOVA with Sidak’s multiple comparison tests. The AUCI for the maximal responses between days 29 and 36 of activin A (A) and IL-17A (B) were compared using Mann-Whitney tests. Each point represents the mean ± SEM for concentrations or mean ± SD for AUC of seven to eight sheep with *and ** representing p ≤ 0.05 and 0.01, respectively). MPC mesenchymal precursor cellsBack to article page